Solaris Resources (TSE:SLS) Reaches New 12-Month High – Time to Buy?

Solaris Resources Inc. (TSE:SLS)’s stock price reached a new 52-week high on Wednesday . The company traded as high as C$15.71 and last traded at C$15.36, with a volume of 234533 shares changing hands. The stock had previously closed at C$14.91.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the stock. BMO Capital Markets increased their target price on shares of Solaris Resources from C$16.00 to C$18.00 in a research report on Thursday, January 29th. National Bank Financial increased their price objective on Solaris Resources from C$20.00 to C$22.50 in a report on Thursday, January 29th. One analyst has rated the stock with a Buy rating, According to MarketBeat.com, Solaris Resources has an average rating of “Buy” and an average target price of C$19.50.

Solaris Resources Trading Up 2.5%

The stock has a market cap of C$2.55 billion, a price-to-earnings ratio of -58.81 and a beta of 1.88. The company has a debt-to-equity ratio of -0.84, a current ratio of 3.09 and a quick ratio of 1.29. The company’s fifty day moving average price is C$12.96 and its 200-day moving average price is C$11.94.

Solaris Resources (TSE:SLS) last released its earnings results on Thursday, March 26th. The company reported C$0.10 EPS for the quarter. On average, research analysts expect that Solaris Resources Inc. will post -0.31 EPS for the current fiscal year.

About Solaris Resources

Solaris Resources is a copper-gold exploration and development company advancing a portfolio of high-quality assets across the Americas. Its flagship asset is the 100%-owned Warintza Project in southeast Ecuador, a Tier 1 copper porphyry deposit with over 1.3 billion tonnes of Mineral Reserves and outstanding economics driven by high-grade, near-surface mineralization and a world-class strip-adjusted grade. Warintza stands out for its scale, simplicity, and strong community partnerships built through formal agreements and inclusive engagement.